MicroRNA binding site polymorphisms as biomarkers in cancer management and research

References

• ZanettiKAHaznadarMWelshJA3′-UTR and functional secretor haplotypes in mannose-binding lectin 2 are associated with increased colon cancer risk in African AmericansCancer Res20127261467147722282660
   PubMed Web of Science ®Google Scholar
• JohnBEnrightAJAravinATuschlTSanderCMarksDSHuman MicroRNA targetsPLoS Biol2004211e36315502875
   PubMed Web of Science ®Google Scholar
• KrekAGrünDPoyMNCombinatorial microRNA target predictionsNat Genet200537549550015806104
   PubMed Web of Science ®Google Scholar
• LewisBPShihIHJones-RhoadesMWBartelDPBurgeCBPrediction of mammalian microRNA targetsCell2003115778779814697198
   PubMed Web of Science ®Google Scholar
• RusinovVBaevVMinkovINTablerMMicroInspector: a web tool for detection of miRNA binding sites in an RNA sequenceNucleic Acids Res200533Web Server issueW696W70015980566
   PubMed Web of Science ®Google Scholar
• KiriakidouMNelsonPTKouranovAA combined computational-experimental approach predicts human microRNA targetsGenes Dev200418101165117815131085
   PubMed Web of Science ®Google Scholar
• ClopAMarcqFTakedaHA mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheepNat Genet200638781381816751773
   PubMed Web of Science ®Google Scholar
• ChenKRajewskyNNatural selection on human microRNA binding sites inferred from SNP dataNat Genet20063812145214617072316
   PubMed Web of Science ®Google Scholar
• MishraPJHumeniukRMishraPJLongo-SorbelloGSBanerjeeDBertinoJRA miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistanceProc Natl Acad Sci U S A200710433135131351817686970
   PubMed Web of Science ®Google Scholar
• LandiDGemignaniFNaccaratiAPolymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancerCarcinogenesis200829357958418192692
   PubMed Web of Science ®Google Scholar
• FilipowiczWBhattacharyyaSNSonenbergNMechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nat Rev Genet20089210211418197166
   PubMed Web of Science ®Google Scholar
• ChenKSongFCalinGAWeiQHaoXZhangWPolymorphisms in microRNA targets: a gold mine for molecular epidemiologyCarcinogenesis20082971306131118477647
   PubMed Web of Science ®Google Scholar
• SaundersMALiangHLiWHHuman polymorphism at microRNAs and microRNA target sitesProc Natl Acad Sci U S A200710493300330517360642
   PubMed Web of Science ®Google Scholar
• HuZChenJTianTGenetic variants of miRNA sequences and non-small cell lung cancer survivalJ Clin Invest200811872600260818521189
   PubMed Web of Science ®Google Scholar
• ChristensenBCMoyerBJAvissarMA let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancersCarcinogenesis20093061003100719380522
   PubMed Web of Science ®Google Scholar
• ChristensenBCAvissar-WhitingMOuelletLGMature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancerClin Cancer Res201016143713372020501619
   PubMed Web of Science ®Google Scholar
• CampayoMNavarroAViñolasNA dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinomaPLoS One201167e2250921799879
   PubMed Web of Science ®Google Scholar
• SalzmanDWWeidhaasJBSNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancerPharmacol Ther20131371556322964086
   PubMed Web of Science ®Google Scholar
• MishraPJMishraPJBanerjeeDBertinoJRMiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomicsCell Cycle 1200877853858
   PubMed Web of Science ®Google Scholar
• MishraPJBertinoJRMicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicinePharmacogenomics200910339941619290790
   PubMed Web of Science ®Google Scholar
• XuJYinZGaoWGenetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese populationPLoS One2013810e7702424146953
   PubMed Web of Science ®Google Scholar
• LudwigJAWeinsteinJNBiomarkers in cancer staging, prognosis and treatment selectionNat Rev Cancer200551184585616239904
   PubMed Web of Science ®Google Scholar
• WuXZhaoHAmosCIp53 Genotypes and Haplotypes Associated with Lung Cancer Susceptibility and EthnicityJ Natl Cancer Inst200294968169011983757
   PubMed Web of Science ®Google Scholar
• GurubhagavatulaSLiuGParkSXPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapyJ Clin Oncol200422132594260115173214
   PubMed Web of Science ®Google Scholar
• SweeneyCNazar-StewartVStapletonPLEatonDLVaughanTLGlutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patientsCancer Epidemiol Biomarkers Prev200312652753312814998
   PubMed Web of Science ®Google Scholar
• TakawaMChoHSHayamiSHistone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expressionCancer Res201272133217322722556262
   PubMed Web of Science ®Google Scholar
• XuJYinZGaoWGenetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese populationPLoS One2013810e7702424146953
   PubMed Web of Science ®Google Scholar
• DingCLiRPengJLiSGuoZA polymorphism at the miR-502 binding site in the 3′ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancerExp Ther Med20123468969222969952
   PubMed Web of Science ®Google Scholar
• XuPLiuLWangJGenetic variation in BCL2 3′-UTR was associated with lung cancer risk and prognosis in male Chinese populationPLoS One201388e7219723977251
   PubMed Web of Science ®Google Scholar
• ZhuWShanXWangTShuYLiuPmiR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell linesInt J Cancer2010127112520252920162574
   PubMed Web of Science ®Google Scholar
• ZhuWXuHZhuDmiR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAPCancer Chemother Pharmacol201269372373121993663
   PubMed Web of Science ®Google Scholar
• SacconiABiagioniFCanuVmiR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancerCell Death Dis20123e42323152059
   PubMed Web of Science ®Google Scholar
• PakunluRIWangYTsaoWPozharovVCookTJMinkoTEnhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery systemCancer Res200464176214622415342407
   PubMed Web of Science ®Google Scholar
• GarbuzenkoOBSaadMPozharovVPReuhlKRMainelisGMinkoTInhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistanceProc Natl Acad Sci U S A201010723107371074220498076
   PubMed Web of Science ®Google Scholar
• ChengMYangLYangRA microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expressionCarcinogenesis201334102292229923715500
   PubMed Web of Science ®Google Scholar
• ElsabaTMMartinez-PomaresLRobinsARThe stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancerPLoS One201055e1071420502714
   PubMed Web of Science ®Google Scholar
• VaughanAEHalbertCLWoottonSKMillerADLung cancer in mice induced by the jaagsiekte sheep retrovirus envelope protein is not maintained by rare cancer stem cells, but tumorigenicity does correlate with Wnt pathway activationMol Cancer Res2012101869522064658
   PubMed Web of Science ®Google Scholar
• Cortes-DericksLGalettaDSpaggiariLSchmidRAKaroubiGHigh expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervalsEur J Cardiothorac Surg2012416e173e18122529186
   PubMed Web of Science ®Google Scholar
• YangZLZhengQYanJPanYWangZGUpregulated CD133 expression in tumorigenesis of colon cancer cellsWorld J Gastroenterol201117793293721412503
   PubMed Web of Science ®Google Scholar
• PatnaikSKKannistoEKnudsenSYendamuriSEvaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resectionCancer Res2010701364520028859
   PubMed Web of Science ®Google Scholar
• MollRFrankeWWSchillerDLGeigerBKreplerRThe catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cellsCell198231111246186379
   PubMed Web of Science ®Google Scholar
• MollRDivoMLangbeinLThe human keratins: biology and pathologyHistochem Cell Biol2008129670573318461349
   PubMed Web of Science ®Google Scholar
• Warnecke-EberzUBaldusSEBollschweilerEHoelscherAHMetzgerRUp-regulation of survivin mRNA might be a marker for non-invasive detection of non-small cell lung cancer rather than for prognosisAnticancer Res2008283A1525152918630507
   PubMed Web of Science ®Google Scholar
• ZuYBanJXiaZGenetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populationsBiochem Biophys Res Commun2013430252953423232114
   PubMed Web of Science ®Google Scholar
• ChinLJRatnerELengSA SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer riskCancer Res200868208535854018922928
   PubMed Web of Science ®Google Scholar
• NelsonHHChristensenBCPlazaSLWienckeJKMarsitCJKelseyKTKRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancerLung Cancer2010691515319854534
   PubMed Web of Science ®Google Scholar
• YangLLiYChengMA functional polymorphism at microRNA-629-binding site in the 3′-untranslated region of NBS1 gene confers an increased risk of lung cancer in Southern and Eastern Chinese populationCarcinogenesis201233233834722114071
   PubMed Web of Science ®Google Scholar
• ZhangSChenHZhaoXREV3L 3′UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibilityOncogene201332224225022349819
   PubMed Web of Science ®Google Scholar
• KnobelPAKotovINFelley-BoscoEStahelRAMartiTMInhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cellsNeoplasia2011131096197022028621
   PubMed Web of Science ®Google Scholar
• XiongFWuCChangJGenetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancerCancer Res201171155175518121676885
   PubMed Web of Science ®Google Scholar
• SmitsKMParanjapeTNallurSA let-7 microRNA SNP in the KRAS 3′UTR is prognostic in early-stage colorectal cancerClin Cancer Res201117247723773121994416
   PubMed Web of Science ®Google Scholar
• KlumpBNehlsOOkechTMolecular lesions in colorectal cancer: impact on prognosis? Original data and review of the literatureInt J Colorectal Dis2004191234212827409
   PubMed Web of Science ®Google Scholar
• WallnerMHerbstABehrensAMethylation of serum DNA is an independent prognostic marker in colorectal cancerClin Cancer Res 152006122473477352
   PubMed Web of Science ®Google Scholar
• LièvreABachetJBBoigeVKRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximabJ Clin Oncol200826337437918202412
   PubMed Web of Science ®Google Scholar
• SebioAParéLPáezDThe LCS6 polymorphism in the binding site of let-7 microRNA to the KRAS 3′-untranslated region: its role in the efficacy of anti-EGFR-based therapy in metastatic colorectal cancer patientsPharmacogenet Genomics201323314214723324806
   PubMed Web of Science ®Google Scholar
• KjersemJBIkdahlTGurenTLet-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin ± cetuximabBMC Cancer2012201253454223167843
   PubMed Web of Science ®Google Scholar
• PardiniBRosaFBaroneEVariation within 3′-UTRs of base excision repair genes and response to therapy in colorectal cancer patients: A potential modulation of microRNAs bindingClin Cancer Res201319216044605624036853
   PubMed Web of Science ®Google Scholar
• WyattMDWilsonDM3rdParticipation of DNA repair in the response to 5-fluorouracilCell Mol Life Sci200966578879918979208
   PubMed Web of Science ®Google Scholar
• IngrahamHATsengBYGoulianMMechanism for exclusion of 5-fluorouracil from DNACancer Res198040499810016101994
   PubMed Web of Science ®Google Scholar
• WallaceSSMurphyDLSweasyJBBase excision repair and cancerCancer Lett20123271–2738922252118
   PubMed Web of Science ®Google Scholar
• KavliBSundheimOAkbariMhUNG2 is the major repair enzyme for removal of uracil from U:A matches, U:G mismatches, and U in single-stranded DNA, with hSMUG1 as a broad specificity backupJ Biol Chem200227742399263993612161446
   PubMed Web of Science ®Google Scholar
• TerzićJGrivennikovSKarinEKarinMInflammation and colon cancerGastroenterology201013862101211420420949
   PubMed Web of Science ®Google Scholar
• SongSChenDLuJNFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese populationPLoS One201166e2172621738780
   PubMed Web of Science ®Google Scholar
• LandiDGemignaniFPardiniBIdentification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAomeCancer2012118194670468022282400
   PubMed Web of Science ®Google Scholar
• GreberUFSeniorAGeraceLA major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tailEMBO J199095149515022184032
   PubMed Web of Science ®Google Scholar
• FavreauCWormanHJWozniakRWFrappierTCourvalinJCCell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210Biochemistry19963524803580448672508
   PubMed Web of Science ®Google Scholar
• RajkumarTSabithaKVijayalakshmiNIdentification and validation of genes involved in cervical tumourigenesisBMC Cancer2011118021338529
   PubMed Web of Science ®Google Scholar
• OrabonaCGrohmannUBelladonnaMLCD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86Nat Immunol20045111134114215467723
   PubMed Web of Science ®Google Scholar
• TaniguchiCMEmanuelliBKahnCRCritical nodes in signalling pathways: insights into insulin actionNat Rev Mol Cell Biol200672859616493415
   PubMed Web of Science ®Google Scholar
• RyanBMRoblesAIHarrisCCGenetic variation in microRNA networks: the implications for cancer researchNat Rev Cancer201010638940220495573
   PubMed Web of Science ®Google Scholar
• NaccaratiAPardiniBStefanoLPolymorphisms in miRNA-binding sites of nucleotide excision repair genes and colorectal cancer riskCarcinogenesis20123371346135122581836
   PubMed Web of Science ®Google Scholar
• JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
   PubMed Web of Science ®Google Scholar
• ChenYCHunterDJMolecular epidemiology of cancerCA Cancer J Clin2005551455415661686
   PubMed Web of Science ®Google Scholar
• McPhersonKSteelCMDixonJMABC of breast diseases. Breast cancer-epidemiology, risk factors, and geneticsBMJ2000321726162462810977847
   PubMed Web of Science ®Google Scholar
• PharoahPDTyrerJDunningAMEastonDFPonderBASEARCH InvestigatorsAssociation between common variation in 120 candidate genes and breast cancer riskPLoS Genet200733e4217367212
   PubMed Web of Science ®Google Scholar
• ZhangBLSongFJZhengHZhangLNZhaoYRChenKXSNP rs16917496 within SET8 3′UTR is associated with the age of onset of breast cancerZhonghua Zhong Liu Za Zhi20123411835837 Chinese23291132
   PubMedGoogle Scholar
• FormaEBrysMKrajewskaWTopBP1 in DNA damage responseKrumanIDNA Repair/Book 4Rijeka, CroatiaINTECH Open Access Publisher2011281304
   Google Scholar
• FormaEBrzeziańskaEKrześlakAAssociation between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancerMol Biol Rep20134053493350223277395
   PubMed Web of Science ®Google Scholar
• XuYJLeffakMATRIP from TopBP1 to ATR – in vitro activation of a DNA damage checkpointProc Natl Acad Sci U S A201010731135611356220660767
   PubMed Web of Science ®Google Scholar
• GloverJNInsights into the molecular basis of human hereditary breast cancer from studies of the BRCA1 BRCT domainFam Cancer20051899315951958
   PubMed Web of Science ®Google Scholar
• XueLLipkinMNewmarkHWangJInfluence of dietary calcium and vitamin D on diet-induced epithelial cell hyperproliferation in miceJ Natl Cancer Inst19999121761819923860
   PubMedGoogle Scholar
• GoodwinPJEnnisMPritchardKIKooJHoodNPrognostic effects of 25-hydroxyvitamin D levels in early breast cancerJ Clin Oncol200927233757376319451439
   PubMed Web of Science ®Google Scholar
• TseGMTanPHCheungHSChuWCLamWWIntermediate to highly suspicious calcification in breast lesions: a radio-pathologic correlationBreast Cancer Res Treat200811011717674189
   PubMed Web of Science ®Google Scholar
• ZhangLLiuYSongFFunctional SNP in the microRNA-367 binding site in the 3′UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcificationProc Natl Acad Sci U S A201110833136531365821810988
   PubMed Web of Science ®Google Scholar
• BrendleALeiHBrandtAPolymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic markerCarcinogenesis20082971394139918550570
   PubMed Web of Science ®Google Scholar
• NovaroVRoskelleyCDBissellMJCollagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cellsJ Cell Sci2003116Pt 142975298612808020
   PubMed Web of Science ®Google Scholar
• LiuJTangXLiMFunctional MDM4 rs4245739 genetic variant, alone and in combination with P53 Arg72Pro polymorphism, contributes to breast cancer susceptibilityBreast Cancer Res Treat2013140115115723793604
   PubMed Web of Science ®Google Scholar
• JiangYQinZHuZGenetic variation in a hsa-let-7 binding site in RAD52 is associated with breast cancer susceptibilityCarcinogenesis201334368969323188672
   PubMed Web of Science ®Google Scholar
• LaoJPOhSDShinoharaMShinoharaAHunterNRad52 promotes postinvasion steps of meiotic double-strand-break repairMol Cell200829451752418313389
   PubMed Web of Science ®Google Scholar
• NicolosoMSSunHSpizzoRSingle-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibilityCancer Res20107072789279820332227
   PubMed Web of Science ®Google Scholar
• ZhengHSongFZhangLGenetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancerInt J Oncol20113841153116121318219
   PubMed Web of Science ®Google Scholar
• LimLPLauNCGarrett-EngelePMicroarray analysis shows that some microRNAs downregulate large numbers of target mRNAsNature2005433702776977315685193
   PubMed Web of Science ®Google Scholar
• NoritakeJWatanabeTSatoKWangSKaibuchiKIQGAP1: a key regulator of adhesion and migrationJ Cell Sci2005118Pt 102085209215890984
   PubMed Web of Science ®Google Scholar
• HollestelleAPelletierCHooningMPrevalence of the variant allele rs61764370 T>G in the 3′UTR of KRAS among Dutch BRCA1, BRCA2 and non-BRCA1/BRCA2 breast cancer familiesBreast Cancer Res Treat20111281798420676756
   PubMed Web of Science ®Google Scholar
• TchatchouSJungAHemminkiKA variant affecting a putative miRNA target site in estrogen receptor (ESR) 1 is associated with breast cancer risk in premenopausal womenCarcinogenesis2009301596419028706
   PubMed Web of Science ®Google Scholar
• FishmanJOsborneMPTelangNTThe role of estrogen in mammary carcinogenesisAnn N Y Acad Sci1995768911008526389
   PubMed Web of Science ®Google Scholar
• MartinGDavioCRiveraEHormone dependence of mammary tumors induced in rats by intraperitoneal NMU injectionCancer Invest19971518179028385
   PubMed Web of Science ®Google Scholar
• ChenWCLaiYHChenHYGuoHRSuIJChenHHInterleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factorHistopathology201363222523323738752
   PubMed Web of Science ®Google Scholar
• WangLLiuWJiangWA miRNA binding site single-nucleotide polymorphism in the 3′-UTR region of the IL23R gene is associated with breast cancerPLoS One2012712e4982323239971
   PubMed Web of Science ®Google Scholar
• ZwiersAKraalLvan de Pouw KraanTCWurdingerTBoumaGKraalGCutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein productionJ Immunol201218841573157722262659
   PubMed Web of Science ®Google Scholar
• PharoahPDPalmieriRTRamusSJOvarian Cancer Association ConsortiumThe role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testingClin Cancer Res201117113742375021385923
   PubMed Web of Science ®Google Scholar
• WynendaeleJBöhnkeALeucciEAn illegitimate microRNA target site within the 3′ UTR of MDM4 affects ovarian cancer progression and chemosensitivityCancer Res201070239641964921084273
   PubMed Web of Science ®Google Scholar
• LiangDMeyerLChangDWGenetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment responseCancer Res201070239765977621118967
   PubMed Web of Science ®Google Scholar
• RatnerELuLBoekeMA KRAS-variant in ovarian cancer acts as a genetic marker of cancer riskCancer Res201070166509651520647319
   PubMed Web of Science ®Google Scholar
• GomaaAIKhanSAToledanoMBWakedITaylor-RobinsonSDHepatocellular carcinoma: epidemiology, risk factors and pathogenesisWorld J Gastroenterol200814274300430818666317
   PubMed Web of Science ®Google Scholar
• CaldwellSParkSHThe epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biologyJ Gastroenterol200944Suppl 199610119148801
   PubMed Web of Science ®Google Scholar
• GuoZWuCWangXWangCZhangRShanBA polymorphism at the miR-502 binding site in the 3′-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcomeInt J Cancer201213161318132222095217
   PubMed Web of Science ®Google Scholar
• ZhouCYuQChenLWangJZhengSZhangJA miR-1231 binding site polymorphism in the 3′UTR of IFNAR1 is associated with hepatocellular carcinoma susceptibilityGene20125071959822824466
   PubMed Web of Science ®Google Scholar
• de WeerdNASamarajiwaSAHertzogPJType I interferon receptors: biochemistry and biological functionsJ Biol Chem200728228200532005717502368
   PubMed Web of Science ®Google Scholar
• ZhangQGongRQuJActivation of the Ras/Raf/MEK pathway facilitates hepatitis C virus replication via attenuation of the interferon-JAK-STAT pathwayJ Virol20128631544155422114332
   PubMed Web of Science ®Google Scholar
• Song leHXuanNTToanNLAssociation of two variants of the interferon-alpha receptor-1 gene with the presentation of hepatitis B virus infectionEur Cytokine Netw200819420421019103527
   PubMed Web of Science ®Google Scholar
• GaoYHeYDingJAn insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′ untranslated region confers risk for hepatocellular carcinomaCarcinogenesis200930122064206919917630
   PubMed Web of Science ®Google Scholar
• WangCZhaoHZhaoXAssociation between an insertion/deletion polymorphism within 3′UTR of SGSM3 and risk of hepatocellular carcinomaTumour Biol201435129530123918301
   PubMedGoogle Scholar
• YuQZhouCXChenNSZhengSDShenLMZhangJKA polymorphism within ErbB4 is associated with risk for hepatocellular carcinoma in Chinese populationWorld J Gastroenterol201218438338722294845
   PubMed Web of Science ®Google Scholar
• MiyamotoHYangZChenYTPromotion of bladder cancer development and progression by androgen receptor signalsJ Natl Cancer Inst 42007997558568
   PubMed Web of Science ®Google Scholar
• TeoMTLandiDTaylorCFThe role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomesCarcinogenesis201233358158622166496
   PubMed Web of Science ®Google Scholar
• AndrewASHuTGuJHSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancerPLoS One2012712e5130123284679
   PubMed Web of Science ®Google Scholar
• BeutenJGelfondJAFrankeJLLeachRJSingle and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancerCancer Epidemiol Biomarkers Prev20091861869188019505920
   PubMed Web of Science ®Google Scholar
• GiampaoloASterpettiPBulgariniDKey functional role and lineage-specific expression of selected HOXB genes in purified hematopoietic progenitor differentiationBlood19948411363736477949119
   PubMed Web of Science ®Google Scholar
• MorganRPlowrightLHarringtonKJMichaelAPandhaHSTargeting HOX and PBX transcription factors in ovarian cancerBMC Cancer2010108920219106
   PubMed Web of Science ®Google Scholar
• LuoJCaiQWangWA microRNA-7 binding site polymorphism in HOXB5 leads to differential gene expression in bladder cancerPLoS One201276e4012722768238
   PubMed Web of Science ®Google Scholar
• ChuHWangMJinHEGFR 3′UTR 774T>C polymorphism contributes to bladder cancer riskMutagenesis2013281495523028094
   PubMed Web of Science ®Google Scholar
• WuXGuJDongQJoint effect of mutagen sensitivity and insulin-like growth factors in predicting the risk of developing secondary primary tumors and tumor recurrence in patients with head and neck cancerClin Cancer Res200612237194720117145846
   PubMed Web of Science ®Google Scholar
• KhuriFRKimESLeeJJThe impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialCancer Epidemiol Biomarkers Prev200110882382911489748
   PubMed Web of Science ®Google Scholar
• ZhangXYangHLeeJJMicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerCarcinogenesis201031122118212320819778
   PubMed Web of Science ®Google Scholar
• ChristensenBCMoyerBJAvissarMA let-7 microRNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancersCarcinogenesis20093061003100719380522
   PubMed Web of Science ®Google Scholar
• LiuZWeiSMaHA functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neckCarcinogenesis201132111668167421934093
   PubMed Web of Science ®Google Scholar
• ParkDJVuongPTde VosSDouerDKoefflerHPComparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arraysBlood2003102103727373612893766
   PubMed Web of Science ®Google Scholar
• SarmaVWolfFWMarksRMShowsTBDixitVMCloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitroJ Immunol199214810330233121374453
   PubMed Web of Science ®Google Scholar
• XuYMaHYuHThe miR-184 binding-site rs8126 T>C polymorphism in TNFAIP2 is associated with risk of gastric cancerPLoS One201385e6497323724109
   PubMed Web of Science ®Google Scholar
• LiZHPanXMHanBWA let-7 binding site polymorphism rs712 in the KRAS 3′ UTR is associated with an increased risk of gastric cancerTumour Biol20133453159316323729275
   PubMedGoogle Scholar
• LinYNieYZhaoJGenetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibilityCarcinogenesis201233122377238322971574
   PubMed Web of Science ®Google Scholar
• WalkerDMUrbéSDoveSKTenzaDRaposoGClagueMJCharacterization of MTMR3 an inositol lipid 3-phosphatase with novel substrate specificityCurr Biol200111201600160511676921
   PubMed Web of Science ®Google Scholar
• StahlMMarietteCHaustermansKCervantesAArnoldDESMO Guidelines Working GroupOesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol2013246vi51vi5624078662
   PubMed Web of Science ®Google Scholar
• WangKLiJGuoHMiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasisCarcinogenesis201233112147215422859270
   PubMed Web of Science ®Google Scholar
• AltschulerDLRibeiro-NetoFMitogenic and oncogenic properties of the small G protein Rap1bProc Natl Acad Sci U S A19989513747574799636174
   PubMed Web of Science ®Google Scholar
• ZhouLZhangXLiZAssociation of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinomaPLoS One201385e6433123724042
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyCancer Facts and Figures 2013Atlanta, GAAmerican Cancer Society2013 Available from: http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc-036845.pdfAccessed July 4, 2014
   Google Scholar
• GomellaLGLiuXSTrabulsiEJScreening for prostate cancer: the current evidence and guidelines controversyCan J Urol20111855875588322018148
   PubMed Web of Science ®Google Scholar
• HughesLRuthKRebbeckTRGiriVNGenetic variation in IL-16 miRNA target site and time to prostate cancer diagnosis in African-American menProstate Cancer Prostatic Dis201316430831424061634
   PubMed Web of Science ®Google Scholar
• LiuJHuangJHeYLiuJLiaoBLiaoGGenetic variants in the integrin gene predicted microRNA-binding sites were associated with the risk of prostate cancerMol Carcinog201453428028523065910
   PubMed Web of Science ®Google Scholar
• GoelHLLiJKoganSLanguinoLRIntegrins in prostate cancer progressionEndocr Relat Cancer200815365766418524948
   PubMed Web of Science ®Google Scholar
• FengNXuBTaoJA miR-125b binding site polymorphism in bone morphogenetic protein membrane receptor type IB gene and prostate cancer risk in ChinaMol Biol Rep201239136937321556765
   PubMed Web of Science ®Google Scholar
• PhamLKLiangMAdisetiyoHAContextual effect of repression of bone morphogenetic protein activity in prostate cancerEndocr Relat Cancer201320686187424042462
   PubMed Web of Science ®Google Scholar
• Surveillance, Epidemiology, and End Results Program (SEER) Stat Fact Sheets: Non-Hodgkin Lymphoma [webpage on the Internet]Bethesda, MDNational Cancer Institute Available from: http://seer.cancer.gov/statfacts/html/nhl.htmlAccessed July 4, 2014
   Google Scholar
• SlagerSLAchenbachSJAsmannYWMapping of the IRF8 gene identifies a 3′UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypesCancer Epidemiol Biomarkers Prev201322346146623307532
   PubMed Web of Science ®Google Scholar
• ChengCKKwanTKCheungCYA polymorphism in the 3′-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemiaHaematologica201398691391723065518
   PubMed Web of Science ®Google Scholar
• CaiolaERulliEFruscioRBudaABrogginiMMarabeseMKRas-LCS6 polymorphism does not impact on outcomes in ovarian cancerAm J Cancer Res20122329830822679560
   PubMed Web of Science ®Google Scholar
• TardatMBrustelJKirshOThe histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cellsNat Cell Biol201012111086109320953199
   PubMed Web of Science ®Google Scholar
• LiZNieFWangSLiLHistone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activationProc Natl Acad Sci U S A201110883116312321282610
   PubMed Web of Science ®Google Scholar
• OdaHOkamotoIMurphyNReinbergDMonomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse developmentMol Cell Biol20092982278229519223465
   PubMed Web of Science ®Google Scholar
• CentoreRCHavensCGManningALCRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phaseMol Cell2010401223320932472
   PubMed Web of Science ®Google Scholar
• ShiXKachirskaiaIYamaguchiHModulation of p53 function by SET8-mediated methylation at lysine 382Mol Cell200727463664617707234
   PubMed Web of Science ®Google Scholar
• MarkeyMPRegulation of MDM4Front Biosci (Landmark Ed)2011161144115621196223
   PubMed Web of Science ®Google Scholar
• LiQLozanoGMolecular pathways: targeting Mdm2 and Mdm4 in cancer therapyClin Cancer Res2013191344123262034
   PubMed Web of Science ®Google Scholar